| Parabilis Medicines, Inc. | 29.2M | US$942M | 9.5% |
| Vaxcyte, Inc. | 11.5M | US$653M | 6.5% |
| Rhythm Pharmaceuticals, Inc. | 6.67M | US$635M | 6.4% |
| Edgewise Therapeutics, Inc. | 8.39M | US$341M | 3.4% |
| Tyra Biosciences, Inc. | 12.2M | US$267M | 2.7% |
| Freenome, Inc. | 15.4M | US$242M | 2.4% |
| Hemab Therapeutics Holdings, Inc. | 7.81M | US$241M | 2.4% |
| Septerna, Inc. | 5.5M | US$215M | 2.2% |
| SpyGlass Pharma, Inc. | 8.02M | US$209M | 2.1% |
| Janux Therapeutics, Inc. | 11.2M | US$193M | 1.9% |
| Mineralys Therapeutics, Inc. | 7.69M | US$193M | 1.9% |
| Disc Medicine, Inc. | 2.45M | US$160M | 1.6% |
| Taysha Gene Therapies, Inc. | 30.4M | US$148M | 1.5% |
| Bicara Therapeutics Inc. | 7.26M | US$135M | 1.4% |
| Artiva Biotherapeutics, Inc. | 18.5M | US$132M | 1.3% |
| Xencor, Inc. | 5.27M | US$132M | 1.3% |
| Oruka Therapeutics, Inc. | 1.55M | US$129M | 1.3% |
| Amylyx Pharmaceuticals, Inc. | 4.28M | US$125M | 1.2% |
| Climb Bio, Inc. | 10.1M | US$116M | 1.2% |
| Abivax SA | 1.03M | US$102M | 1.0% |
| Latigo Biotherapeutics, Inc. | 5.3M | US$88.6M | 0.89% |
| Solid Biosciences Inc. | 12M | US$87M | 0.87% |
| Vor Biopharma Inc. | 4.5M | US$85.9M | 0.86% |
| LB Pharmaceuticals Inc | 2.21M | US$84.8M | 0.85% |
| Obsidian Therapeutics, Inc. | 5.96M | US$81.8M | 0.82% |
| Zai Lab Ltd. | 2.82M | US$74.2M | 0.74% |
| 4D Molecular Therapeutics, Inc. | 5.05M | US$72.3M | 0.72% |
| Aclaris Therapeutics, Inc. | 12.7M | US$66.9M | 0.67% |
| Sana Biotechnology, Inc. | 18.8M | US$54.7M | 0.55% |
| Monopar Therapeutics Inc. | 667K | US$53.2M | 0.53% |
| Geron Corporation | 42.8M | US$52.6M | 0.53% |
| PepGen Inc. | 20.1M | US$48.6M | 0.49% |
| ARS Pharmaceuticals, Inc. | 10.9M | US$46.8M | 0.47% |
| Acumen Pharmaceuticals, Inc. | 21M | US$46.6M | 0.47% |
| DBV Technologies SA | 3.66M | US$43M | 0.43% |
| Agenus Inc. | 4.12M | US$40.9M | 0.41% |
| Rezolute, Inc. | 9.45M | US$39.1M | 0.39% |
| Sionna Therapeutics, Inc. | 6.46M | US$34M | 0.34% |
| Scribe Therapeutics Inc. | 1.8M | US$33.2M | 0.33% |
| Century Therapeutics, Inc. | 17.8M | US$30.4M | 0.30% |
| Evommune, Inc. | 3.49M | US$28.9M | 0.29% |
| Capricor Therapeutics, Inc. | 3.01M | US$28.5M | 0.29% |
| Nkarta, Inc. | 10.8M | US$28.3M | 0.28% |
| C4 Therapeutics, Inc. | 8.19M | US$27.3M | 0.27% |
| Jade Biosciences, Inc. | 1.84M | US$25.8M | 0.26% |
| Prelude Therapeutics Incorporated | 6.48M | US$25.3M | 0.25% |
| Acrivon Therapeutics, Inc. | 12.2M | US$25.1M | 0.25% |
| Assembly Biosciences, Inc. | 1.02M | US$24M | 0.24% |
| Editas Medicine, Inc. | 8.89M | US$22.8M | 0.23% |
| Q32 Bio Inc. | 2.33M | US$19.3M | 0.19% |
| Anteris Technologies Global Corp. | 2.47M | US$19.2M | 0.19% |
| Electra Therapeutics, Inc. | 1.69M | US$19M | 0.19% |
| Altimmune, Inc. | 6.5M | US$18.6M | 0.19% |
| Benitec Biopharma Inc. | 1.85M | US$18.5M | 0.19% |
| ALX Oncology Holdings Inc. | 13M | US$18.1M | 0.18% |
| Sagimet Biosciences Inc. - Series A | 1.8M | US$17.8M | 0.18% |
| Lexeo Therapeutics, Inc. | 5M | US$16.9M | 0.17% |
| LENZ Therapeutics, Inc. | 4.18M | US$16M | 0.16% |
| Aura Biosciences, Inc. | 2.5M | US$15.7M | 0.16% |
| Avalo Therapeutics, Inc. | 1M | US$15.3M | 0.15% |
| Inhibikase Therapeutics, Inc. | 6.97M | US$14.3M | 0.14% |
| Seaport Therapeutics, Inc. | 700K | US$14.1M | 0.14% |
| SAB Biotherapeutics, Inc. | 4.4M | US$14M | 0.14% |
| Ovid Therapeutics Inc. | 5.6M | US$13.9M | 0.14% |
| Mirum Pharmaceuticals, Inc. | 159K | US$13.6M | 0.14% |
| Helix Acquisition Corp. III | 1.25M | US$13.3M | 0.13% |
| Bright Minds Biosciences Inc. | 265K | US$13.2M | 0.13% |
| Corbus Pharmaceuticals Holdings, Inc. | 1.91M | US$13.1M | 0.13% |
| Braveheart Bio, Inc. | 565K | US$11.4M | 0.11% |
| OnKure Therapeutics, Inc. | 4M | US$10.9M | 0.11% |
| Palisade Bio, Inc. | 7.12M | US$9.62M | 0.10% |
| Inovio Pharmaceuticals, Inc. | 7.22M | US$8.81M | 0.09% |
| MacroGenics, Inc. | 1.86M | US$7.2M | 0.07% |
| Rani Therapeutics Holdings, Inc. | 8.5M | US$6.72M | 0.07% |
| Adicet Bio, Inc. | 933K | US$6.66M | 0.07% |
| TCGX Acquisition Corp. | 500K | US$6.25M | 0.06% |
| Sensei Biotherapeutics, Inc. | 205K | US$6.1M | 0.06% |
| JATT II Acquisition Corp | 500K | US$5.62M | 0.06% |
| JATT III Acquisition Corp | 450K | US$4.96M | 0.05% |
| Amanat Acquisition Corp | 375K | US$4M | 0.04% |
| Equillium, Inc. | 2.32M | US$3.77M | 0.04% |
| Sutro Biopharma, Inc. | 211K | US$3.4M | 0.03% |
| Stoke Therapeutics, Inc. | 73,607 | US$1.91M | 0.02% |
| Palatin Technologies, Inc. | 62,124 | US$551K | <0.01% |
| Werewolf Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Karyopharm Therapeutics Inc. | 0 | US$0 | 0.00% |
| Intellia Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Nuvalent, Inc. | 0 | US$0 | 0.00% |
| Perceptive Capital Solutions Corp | 0 | US$0 | 0.00% |
| Waystar Holding Corp. | 0 | US$0 | 0.00% |
| Aktis Oncology, Inc. | 0 | US$0 | 0.00% |
| BioCryst Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| BioAge Labs, Inc. | 0 | US$0 | 0.00% |
| Corvus Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Definium Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Damora Therapeutics, Inc. | 0 | US$0 | 0.00% |